Healio selected as CancerX 2025 Accelerator media partner
Key takeaways:
- Healio is the official media partner for the CancerX 2025 Accelerator cohort.
- The cohort is comprised of innovative startups focused on addressing critical challenges in oncology.
Healio is pleased to announce its partnership with CancerX, a public-private collaboration dedicated to the acceleration of innovation in cancer treatment.
Healio has been selected as the official media partner for the CancerX 2025 Accelerator cohort, a group of innovative digital health and artificial intelligence startups focused on addressing critical challenges in oncology.
“Healio is honored to be chosen as a champion and serve as the CancerX Accelerator media partner,” said Joan-Marie Stiglich, ELS, Healio’s chief content officer. “We’re excited to share the groundbreaking innovations created by the 2025 Accelerator Cohort with the wider oncology community.”
The CancerX Accelerator program connects unmet needs within champion organizations with cutting-edge innovations from startups in the field.
Startups within the Accelerator cohort may be championed by one or more organizations and receive a range of support, from mentorship and product feedback to conducting pilots and signing commercial agreements.
The 4-month program also provides a weekly curriculum that educates startups about working with health systems, industry and the public sector, as well as how to scale their business within oncology.
This year’s cohort will focus on advancing cancer care by improving access to treatment, accelerating clinical trials and providing personalized, connected care for patients beyond the clinic.
Healio will highlight these breakthroughs and achievements through exclusive, in-depth interviews with the 2025 Accelerator cohort members, as well as alumni groups from last year’s program.
Moffitt Cancer Center currently hosts CancerX. Thirteen entities have been selected as Accelerator Champions: Advocate Health, CEI Ventures, Dana-Farber Cancer Institute, Elevance, Flare Capital Partners, Innsena, Johnson & Johnson, KidsX, MassChallenge, Memorial Sloan Kettering Cancer Center, Mercury, Oncology Ventures and the Assistant Secretary of Technology Policy.
“We’re thrilled to welcome Healio as a media partner. With Healio’s extensive network of 2 million physicians, this partnership will provide invaluable exposure for the 14 startups in the Accelerator and enable seamless sharing of CancerX’s ecosystem and content with a broader healthcare audience,” said Kamal Jethwani, MD, MPH, vice president for digital ventures at Moffitt Cancer Center.
This year’s cohort includes First Ascent Biomedical, We Are Here, Xploro, Fifth Eye, Encapsulate, Nen, Recursive Health, Gabbi, Dyania Health, AIQ Solutions, Manta Cares, Arcascope, Citrus Oncology and mPATH Health.
Join the CancerX community here.